Recently, a water extract from sporoderm-breaking spores of Ganoderma lucidum (ESG) (oral administration, 400 mg/kg) was shown to downregulate the immune checkpoint molecules PD-1 and CTLA-4, thus restoring T cell functionality and enhancing tumor immune surveillance in tumor-bearing mice [113]. This evidence concerns the gene CTLA4 and neoplasm.